Curie Limited is a start-up from Hong Kong.
Our team has successfully developed the C-POLAR™ technology, a revolutionary technology that uses a positive polarity charge to capture and kill viruses and microbes by targeting their negative charged proteins, unlike any other antiviral and antimicrobial agents and we call this polarceutical (Polarity Pharmaceutical). Since we are targeting to physically disrupt the protein structure of viruses and bacteria, our polarceutical technology can effect wide-ranged antimicrobial actions through non-chemical and non-electrical means.
Curie Limited designs and manufactures the C-POLAR™ material to supply to different industries that demand antimicrobial technology.
|Nature of Business